首页> 美国卫生研究院文献>Gynecologic Oncology Case Reports >Endometrioid adenocarcinoma associated with endometrial stromal sarcoma: A rare often unrecognized collision tumor
【2h】

Endometrioid adenocarcinoma associated with endometrial stromal sarcoma: A rare often unrecognized collision tumor

机译:子宫内膜样腺癌与子宫内膜间质肉瘤相关:一种罕见的常常未被认识的碰撞肿瘤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

We are reporting 3 cases of the uterine corpus with collision of endometrioid adenocarcinoma (EAC) with endometrial stromal sarcoma (ESS). The patients' ages ranged from 36 to 59 years old. The major clinical presentation was abnormal uterine bleeding. Microscopically, all 3 cases presented with 2 separate components, EAC Grade 1 and ESS (one low grade and two high grades). The EAC component ranged from 10% to 70%, and the ESS component ranged from 30% to 70% of total tumor volume. The EAC component was stage 1A in two cases and stage II in one case. The ESS component was stages IA, IIB, and IIIB. Adjuvant hormonal therapy was administrated to one patient while a second patient was treated with chemo/radiation therapy. Two patients were still alive with no evidence of disease at 4 years post-therapy. One patient was lost for follow-up. Collision tumor should be distinguished from carcinosarcoma due to its different treatment modality, outcome and, prognosis.
机译:我们报告3例子宫内膜异位子宫内膜样腺肉瘤(ESS)子宫内膜样腺癌(EAC)碰撞。患者的年龄为36至59岁。主要临床表现为异常子宫出血。在显微镜下,所有3例均表现为2个单独的成分,EAC 1级和ESS(一个低级和两个高级)。 EAC成分占肿瘤总体积的10%至70%,而ESS成分占肿瘤总体积的30%至70%。 EAC成分为2例为1A期,其中1例为II期。 ESS组成部分为阶段IA,IIB和IIIB。一名患者接受了激素辅助治疗,而另一名患者接受了化学/放射治疗。两名患者在治疗后4年还活着,没有任何疾病的迹象。一名患者失访。碰撞肿瘤应与癌肉瘤区分开,因为其治疗方式,结果和预后不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号